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Abstract 
Rhamnose is an important 6-deoxy sugar present in many natural products, glycoproteins, 
and structural polysaccharides. Whilst predominantly found as the L-enantiomer, instances 
of D-rhamnose are also found in nature, particularly in the Pseudomonads bacteria. 
Interestingly, rhamnose is notably absent from humans and other animals, which poses 
unique opportunities for drug discovery targeted towards rhamnose utilising enzymes from 
pathogenic bacteria. Whilst the biosynthesis of nucleotide-activated rhamnose (NDP-
rhamnose) is well studied, the study of rhamnosyltransferases that synthesise rhamnose-
containing glycoconjugates is the current focus amongst the scientific community.  
In this review, we describe where rhamnose has been found in nature, as well as what is 
known about TDP-β-L-rhamnose, UDP-β-L-rhamnose, and GDP-α-D-rhamnose biosynthesis. 
We then focus on examples of rhamnosyltransferases that have been characterized using 
both in vivo and in vitro approaches from plants and bacteria, highlighting enzymes where 
3D structures have been obtained. The ongoing study of rhamnose and 
rhamnosyltransferases, in particular in pathogenic organisms, is important to inform future 
drug discovery projects and vaccine development.  
Background 
Rhamnose (Rha) is a 6-deoxy hexose sugar found widely throughout nature in plant and 
microbial natural products (1), including glycoproteins (2) and structural polysaccharides (3). 
The importance of these glycoconjugates in biological processes leads to rhamnose often 
being an essential sugar for cell viability in many organisms. Although the L- enantiomer of 
rhamnose is by far the most abundant throughout nature, D-Rha has been found extensively 
throughout the Pseudomonas genus (4) as a constituent of their surface exposed 
lipopolysaccharide (5). Animal production of biological compounds based on L-rhamnose 
have not been found. Thus, the microbial biosynthesis pathway for L-Rha production has 
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previously been targeted as a potential therapeutic drug target to fight bacterial infections 
(3, 6).   
 
The biosynthesis pathways of the nucleotide-activated forms of L- and D-Rha differ 
depending on the enantiomer and the domain of life. L-Rha is biosynthesized as two 
variants, thymidine 5’-diphospho-β-L-rhamnose (TDP-β-L-rhamnose) or uridine 5’-
diphospho-β-L-rhamnose (UDP-β-L-rhamnose). D-Rha is much less common and is 
biosynthesized as GDP-α-D-rhamnose, using a different set of enzymes to those utilised in 
the NDP-β-L-rhamnose biosynthesis pathways. Bacteria (7), some microalgae (8), and 
archaea (9), have been shown to primarily produce TDP-β-L-rhamnose, whilst the 
biosynthesis of UDP-β-L-rhamnose is mainly observed in plants or other eukaryotes such as 
fungi and algae, on large, multifunctional enzymes (10, 11). GDP-α-D-rhamnose has been 
observed in the Pseudomonas genus (12), Aneurinibacillus thermoaerophilus (13), and also 
the giant algal-infecting virus, Paramecium bursaria Chlorella virus 1 (14). 
 
Following nucleotidyl-activation, NDP-Rha becomes a substrate for diverse 
rhamnosyltransferases that transfer rhamnose onto their glycoconjugate products. Many of 
the functionally characterized rhamnosyltransferases are responsible for the transfer of L-
Rha to bacterial LPS (15-18), but other rhamnosyltransferases that transfer rhamnose to 
plant natural products have also been described (19-21). In this work, we review the 
presence of rhamnose in glycoconjugates across the domains of life and viruses, with a 
particular focus on Gram-negative and Gram-positive pathogenic bacteria, which are 
classified by their rhamnose-rich surface carbohydrate virulence factors, where rhamnose is 
abundant and found with a variety of linkages. We also review the rhamnosyltransferases 
that have been characterised structurally and highlight some limitations that currently 
hinder the progress towards the elucidation of other rhamnosyltransferases from a 
functional and structural perspective.  
 




Although notably absent from animals and mammals, rhamnose plays a crucial role for 
plants and a number of lower eukaryotes. Arguably, the most prominent rhamnose 
glycoconjugate found in land plants is the pectic polysaccharide rhamnogalacturonan-I (RG-
I). In this glycoconjugate, α-L-Rha forms the backbone repeating unit of 4)-α-D-GalpA-(1,2)-
α-L-Rhap-(1, and is the branching point for the sidechains (Figure 1). Rhamnose is therefore 
an essential sugar to the polysaccharide structure. Pectic polysaccharides like RG-I, along 
with other polysaccharides, constitute the major component of the plant cell wall, and are 
crucial for cell wall flexibility and stability, but also essential for growth and plant 
development (22). As well as RG-I, rhamnose frequently decorates flavonoids such as 
kaempferol and quercetin, often found in the flowering tissues of plants (23). The 
glycosylation of these flavonoids is believed to prevent self-toxicity; importantly, when 
flavonol glycosylation is genetically blocked, some plants down-regulate flavonol aglycone 




The presence of rhamnose in fungal glycoconjugates is less common, but the filamentous 
human pathogen Pseudallescheria boydii, as well as the plant pathogen, 
Rhynchosporium secalis (25), produce a distinct rhamnose-containing cell wall 
polysaccharide termed ‘peptido-rhamno-mannan’, which has been proposed as a potential 
diagnostic marker due to its rarity (26). Other eukaryotes such as algae are known to 
biosynthesise nucleotide-activated rhamnose (8) and produce prominent rhamnose-
containing polysaccharides. Worth mentioning is the sulphated structural polysaccharide, 
ulvan, from the green ‘sea lettuce’ of the Ulva genus. It consists of either 4)-β-D-GlcA-(1-4)-
α-L-Rha-3S-(1 or alternatively 4)-α-D-IdoA-(1-4)-α-L-Rha-3S-(1 repeating units and has been 
found to display useful pharmaceutical or nutraceutical properties (27). It has even been 
recommended as a food source to improve the egg laying ability of hens (28). Rhamnose has 
also been identified to be a major component of other algal polysaccharides, but their 
chemical structures and carbohydrate compositions have not been yet elucidated (29, 30). 
Rhamnose and rhamnose biosynthesis genes and subsequent enzymes are absent in higher 
eukaryotes, including mammals. This uniqueness suggests that these family of enzymes that 
are mechanistically distinct to any proteins found in the hosts are potential drug targets in 





Whilst less common in eukaryotes, rhamnose appears to be ubiquitously incorporated into 
surface carbohydrates amongst both Gram-negative and Gram-positive bacteria. The Gram-
negative O-antigen is often the exclusive component that incorporates rhamnose, with 
structural diversity arising from the linkage types, repeating units, and the substitution of 
the core backbone. As well as being found in the E. coli O-antigens, L-Rha makes up the 
major component of the surface carbohydrates in the pathogenic Shigella O-antigens. 
Shigella are composed of four subgroups (S. flexneri, S. sonnei, S. dysenteriae, and S. boydii), 
which are further categorised into serotypes; these serotypes are identified based on the 
carbohydrate structure of the lipopolysaccharide repeat units of the O-antigen. Rhamnose is 
often the major component of these repeating units and forms the backbone of them, with 
carbohydrate diversity arising in the glycosidic linkage type and substitutions (31) (Figure 1).  
 
Like Shigella, the Streptococcus genus is grouped based on the carbohydrate composition of 
the antigens found on their cell wall and its ability to trigger unique immune responses. This 
grouping, first described by Rebecca Lancefield in 1933 (32), has prompted the study of the 
chemical structure and composition of numerous Streptococcal Lancefield antigens, which 
have since been found to contain rhamnose as their major substituent. These rhamnose-rich 
surface polysaccharides are currently being studied as a potential vaccine candidate against 
Group A Streptococcus (GAS), both by academics and the pharmaceutical industry (33-35). 
As well as species from GAS such as Streptococcus pyogenes, the streptococcus genus 
contains important pathogens to humans and animals, with GAS being the causative agent 
for a variety of diseases such as streptococcal pharyngitis (strep throat), scarlet fever and 
autoimmune disease such as rheumatic heart disease (36). Group B Streptococcus (GBS) is 
an important human pathogen; although mostly harmless in adults it can be fatal if passed 
from a pregnant mother to a newborn baby (37). Importantly, GBS is also a bovine 
pathogen, similarly to other Lancefield bacteria from groups C, D, F, and G, which are both 
human and animal pathogens (38). The Group A Carbohydrate (GAC) was the first cell wall 
carbohydrate reported as a virulence determinant for Group A Streptococcus (33), and 
similar studies on other Group carbohydrates are eagerly awaited. Some species such as the 
oral pathogen Streptococcus mutans and other Streptococci from the viridans group do not 
belong to a conventional Lancefield group due to the lack of a group specific antigen. 
Nonetheless, these strains also produce cell wall polysaccharides similar to the Lancefield 
Streptococci that are rich in rhamnose and have been found to be vital for pathogenesis (39) 
(Figure 1). In addition to the observations made for S. mutans, previous work has 
emphasized the crucial role of the rhamnose-containing Lancefield antigens from GAS and 
GBS in pathogenesis (33, 40). Work is ongoing to unravel the complex structures behind 
some of these carbohydrates, but GAS has previously been shown to contain a rhamnose 
backbone of alternating α1-2, α1-3 linkages, periodically decorated with N-
acetylglucosamine residues (41, 42); more recently it has been found to contain periodic 
decorations of glycerol-phosphate on the side chains of the carbohydrate GlcNAc (43) 
(Figure 1). The same negative charge decoration has also been observed in SCC and was 
proposed to be present in many more Streptococci (41). The Group B Carbohydrate (GBC) is 
unique from other streptococcal Lancefield antigens as it forms a multiantenna branched 
structure, with an adapter region to link it to the peptidoglycan layer (44, 45). Importantly, 
the GBC, like other Lancefield antigens, are rich in rhamnose in both the adapter region and 
repeat unit of the carbohydrate (Figure 1). Moreover, it was recently shown that the 
majority of streptococcal rhamnose polysaccharides from almost all Lancefield groups are 
synthesised via a conserved GlcNAc-rhamnose initiator disaccharide (17). Most annotated 
rhamnosyltransferase genes and the TDP-rhamnose biosynthesis genes have been reported 
as being essential in Group A, B and C Streptococcus (33, 46). 
 
Another genus of bacteria found to contain rich rhamnose cell wall polysaccharides is the 
gram-positive Lactobacillus genus. Famous for their ability to convert sugars into lactic acid, 
the Lactobacilli spp. form a major component of a healthy gut microbiota (47). Lactobacillus 
casei BL23, a species used extensively for fermentation purposes, has recently been found 
to contain a rhamnose rich cell wall polysaccharide structurally related in parts to 
Streptococcal Lancefield antigens, however synthesised in heptasaccharide repeat units, 
which are branched on the rhamnose sugars. The GalNAc-rhamnose backbone is decorated 
with glucose or n-acetylglucosamine side chains forming the core heptasaccharide repeating 
unit (48). L. lactis has also been found to produce a cell wall polysaccharide containing 
rhamnose (49), and interestingly the biosynthesis gene cluster for cell wall polysaccharide 
biogenesis in L. lactis has been shown to share similarities with the Lancefield antigen gene 
clusters from Streptococcus (3). Each of these gene clusters starts with one or more of the 
biosynthetic genes for TDP-α-L-rhamnose biosynthesis, highlighting the importance of 
rhamnose in these diverse cell wall polysaccharides (3). The most recently characterised 
rhamnose containing polysaccharide is the enterococcal polysaccharide antigen from 
vancomycin resistant Enterococcus faecalis (50, 51). The reported gene clusters contain in 
fact three pathways, i) TDP-Rha biosynthesis, ii) the rhamnan backbone biosynthesis cluster 
and iii) repeat unit biosynthesis.  
 
Several bacteria contain the rhamnose-rich S-layer, an array of abundant proteins or 
glycoproteins found on the surface (S-layer) of walled bacteria and archaeal envelopes. As 
with other post-translational modifications, the proteins found in the S-layer are 
glycosylated (typically N-glycosylation) to add a layer of further complexity to the 
proteinaceous structure. Rhamnose has been found as a component of several bacterial S-
layers, for instance as polyrhamnan in the S-layer of Geobacillus stearotherophilus (2, 52). 
Another example is that rhamnose is incorporated into the complex N-glycan structure from 
Paenibacillus alvei (53) (Figure 1). Although less widespread, rhamnose has also been found 
in the S-layer of some archaea as a response to different growth conditions (54). 
 
Whilst L-Rha is much more common across all domains of life than the D-enantiomer, the 
Gram-negative  plant, animal, and human pathogen, Pseudomonas aeruginosa, produces a 
common polysaccharide antigen on its LPS made up solely of D-Rha residues (55). These 
antigenic regions have been found to contain an average of ~70 D-Rha residues per 
molecule, making them a major component of the P. aeruginosa cell surface. Previous work 
has shown that P. aeruginosa mutants that lack the ability to produce GDP-D-rhamnose are 
significantly less efficient at adhering to human bronchial epithelial cells, suggesting that 
these large D-Rha rich antigenic common polysaccharide antigens may play an important 







Although the glycobiology of viruses is less understood than eukaryotes or bacteria, with 
many viruses hijacking host glycosylation machinery for capsid glycosylation, it has recently 
been shown that viruses do produce rhamnose glycoconjugates. The giant Chlorella virus, 
Paramecium bursaria chlorovirus PBCV-1, synthesises highly complex N-glycans decorated 
on the major capsid protein that contain both L- and D-Rha (57, 58) and are the first 
reported viral species that produce both enantiomers (Figure 1). Mimivirus has also been 
found to contain high amounts of L-Rha in its fibers (59). Interestingly, unlike other viruses, 
giant viruses such as mimivirus and PBCV-1 appear to encode most of the glycosylation 
machinery in their large genomes for autonomous glycosylation. PBCV-1 has been found to 
encode a functional GDP-L-fucose biosynthesis pathway, which also produces the rare GDP-
D-rhamnose as a major product (14), and mimivirus has been shown to contain a 




The biosynthesis of NDP-β-L-rhamnose has been studied extensively in bacteria and plants, 
and more recently microalgae and giant viruses have even had their NDP-β-L-rhamnose 
biosynthesis pathways discovered (8, 60). Production of nucleotide-activated L-Rha arises 
from either the Rml pathway (commonly found in bacteria) or the NRS/ER or RHM pathways 
(commonly found in plants and other eukaryotes) (Fig. 2). Whilst there are examples of 
some enzyme promiscuity in vitro in each pathway (8, 10, 61), the Rml pathway primarily 
produces TDP-β-L-rhamnose and the NRS/ER or RHM pathway primarily produces UDP-β-L-




TDP-β-L-rhamnose is the most commonly found rhamnose nucleotide sugar and is 
ubiquitous amongst gram-negative and gram-positive bacteria, where it serves as a 
common component of the O-antigen of lipopolysaccharides, as previously discussed. 
Biosynthesis of TDP-β-L-rhamnose commonly follows a four-step route, starting with the 
production of TDP-α-D-glucose by the thymidylyltransferase RmlA. The three other chemical 
modifications of the substrate TDP-α-D-glucose include 1) dehydration (RmlB – 4,6 
dehydratase), 2) epimerization (RmlC – 3,5-epimerase), and subsequent 3) reduction (RmlD 
– 4-reductase) to produce TDP-β-L-rhamnose. Interestingly, the four Rml genes (rmlA-D) 
that encode the complete pathway are often found clustered in bacteria. Conversely, the 
Streptococci from more than 40 different species, including Group A, C and G Streptococci, 
do not cluster rmlA-D (62). Streptococcus pyogenes contains RmlD (GacA) in a separate 
cluster to the rest of the Rml pathway, at the start of the cluster responsible for Lancefield 
antigen biosynthesis (62, 63). Van der Beek et al., showed that this novel monomeric 
homolog of RmlD is essential for Group A Streptococcus, and thus represents a good 
therapeutic target for drug discovery (63).  Homologs of RmlB, RmlC and RmlD have been 
studied for many years, with all having had their crystal structures solved (64-66). Van der 
Beek also targeted recombinantly expressed and purified RmlBC and GacA (RmlD) from 
Streptococcus pyogenes in a small compound inhibitor screen, highlighting one compound 
that inhibited both the growth of S. pyogenes but also the rhamnose-dependant 
Mycobacterium tuberculosis (62). Alphey et al., have previously targeted purified RmlA from 
Pseudomonas aeruginosa for inhibitor identification, using a combination of high-
throughput screening, and subsequent optimization using protein crystallography, in silico 
screening, and chemical synthesis. This vigorous approach yielded nanomolar inhibitors of P. 




Research into UDP-β-L-rhamnose biosynthesis in eukaryotes is more recent, but the 
multidomain Arabidopsis thaliana enzyme, RHM, has drawn particular biotechnological 
attention for its ability to convert as a single protein UDP-α-D-glucose to UDP-β-L-rhamnose,  
via the three common enzymatic steps: dehydration, epimerization, and reduction of the 
Rml pathway (11, 68) (Figure 2). Pei et al., fused an RHM homolog from Vitis vinifera to a 
bifunctional NRS/ER enzyme from A. thaliana, resulting in a self-sufficient NADPH-
independent enzyme able to convert UDP-α-D-glucose to UDP-β-L-rhamnose (68). As well as 
the RHM pathway, A. thaliana encodes for the NRS/ER pathway, where the three conserved 
reaction steps are conducted by two enzymes only (10). This pathway is also found in other 
eukaryotes such as fungi (61), where it is essential for pathogenicity in some species (69). 
The NRS/ER pathway is also present in giant viruses (60), where both L- and D- enantiomers 
of rhamnose are found in complex N-glycans (57). Whilst most species of algae appear to 
encode for either the RHM or NRS/ER pathway, depending on their eukaryotic origin, 
Wagstaff et al. recently reported a novel RmlC/RmlD fusion protein in the Haptophycaea 
and Alveolata phyla. The authors suggested that this chimera was likely the result of 




Unlike L-Rha which is activated with either uridine or thymidine, D-Rha is biosynthesized as 
guanidine 5’-diphospho-α-D-rhamnose (GDP-α-D-rhamnose) by the actions of a GDP-α-D-
mannose 4,6-dehyratase (GMD) (14, 70) and a GDP-6-deoxy-D-lyxo-4-hexulose reductase 
(13) (Figure 2). The presence of D-Rha and the responsible biosynthetic pathway are much 
less common across all domains of life. Like the L-Rha pathways, the sugar ring is first 
dehydrated by the enzyme GDP-mannose 4,6-dehydratase, before undergoing subsequent 
stereoselective reduction at position 4 to produce GDP-α-D-rhamnose. This pathway has 
evolved to show some level of promiscuity in the end product, with reduction to the 
alternative stereoisomer resulting in GDP-α-D-talose, or an additional 3,5-epimerisation step 
before reduction resulting in GDP-ß-L-fucose. GDP-α-D-mannose 4,6-dehydratases (GMD) 
have been found in many organisms due to their ability to produce the precursors for the 
biosynthesis of GDP-α-D-rhamnose, GDP-α-D-talose, and GDP-β-L-fucose. However, the 
characterized GDP-4-keto-rhamnose reductases (Rmd) that produces specifically GDP-α-D-
rhamnose are less conserved but have been reported in Aneurinibacillus thermoaerophilus 
and Pseudomonas aeruginosa (12, 13), which produce D-Rha as a major substituent of their 
respective LPS, as discussed previously. Interestingly, a GMD enzyme from Paramecium 
bursaria Chlorella virus 1 has been shown to have both 4,6-dehydratase and 4-reductase 
activity, leading to a promiscuous production of GDP-α-D-rhamnose and GDP-ß-L-fucose 





Rhamnosyltransferases are the catalytic enzymes that are responsible for the transfer of 
rhamnose to the target glycoconjugate. Using nucleotide-activated rhamnose (NDP-Rha) as 
a sugar donor, rhamnosyltransferases can transfer one or multiple rhamnose residues to a 
diverse range of acceptor molecules. These range from small natural products such as plant 
flavonoids, to much larger polysaccharides within bacterial LPS (Table 1). Recombinant 
production and purification of glycosyltransferases are often challenging, due to their 
nature of being commonly membrane associated, multidomain proteins. Furthermore, the 
acceptor substrates are often chemically unusual, and the enzymes require elaborate 
substrates that cannot be easily mimicked or synthesised for in vitro studies. Therefore, a lot 
of work that has been reported on functionally characterized rhamnosyltransferases 
involves the genetic manipulation of the host organism, and subsequent metabolite 
profiling to identify changes in levels of rhamnosylation of target products.  
 
 
Eukaryotic rhamnosyltransferases characterized using genetic manipulation 
 
The pectic polysaccharide RG-I is arguably the most notorious rhamnose containing cell wall 
polysaccharide in land plants. Recently, Takenaka et al., were able to functionally 
characterize the rhamnosyltransferases from Arabidopsis thaliana that are responsible for 
the transfer of rhamnose from UDP-ß-L-rhamnose to RG-I oligosaccharides (RRTs) (94). In 
this work, the authors found that RRT1, which is one of four rhamnosyltransferases 
responsible for generation of RG-I, is a single-spanning transmembrane protein that is highly 
expressed during the formation of seed coat mucilage – a specialized cell wall component 
abundant with RG-I. In agreement with its proposed function, inactive mutants of RRT1 
resulted in a reduction in levels of RG-I in seed coat mucilage.  
 
Other rhamnosyltransferases from plants that have been analysed using genetic 
manipulation approaches include the β-solanine/β-chaconine rhamnosyltransferase, SGT3, 
from Solanum tuberosum (20). Steroidal glycoalkaloids are often harmful speciality 
metabolites found in Solanaceous plants and include α-solanine and α-chaconine, two tri-
glycosylated alkaloids that accumulate in potato tubers. Using antisense downregulation of 
Sgt3, McCue et al., were able to show that SGT3 is responsible for the transfer of rhamnose 
to the first galactose or glucose residue of β-solanine or β-chaconine, respectively (20). 
Downregulation of Sgt3 resulted in accumulation of both β -solanine and β-chaconine in 
tubers, with a concomitant reduction in levels of α-solanine and α-chaconine.  
 
Prokaryotic rhamnosyltransferases characterized using genetic manipulation 
 
Pseudomonas produce glycoconjugates containing both L- and D-Rha, including virulence 
factors such as extracellular rhamnolipids that contain one (mono-rhamnolipid) or two (di-
rhamnolipid) L-Rha residues. Rhamnosyltransferase 1 (RhlAB) is known to transfer the first 
rhamnose residue from TDP-ß-L-rhamnose to ß-hydroxydecanoyl-ß-hydroxydecanoate. 
Rahim et al. characterized the function of the rhlC gene product as the second 
rhamnosyltransferase, responsible for the generation of di-rhamnolipid (85). In this work 
the authors were able to generate a chromosomal mutant of rhlC which was subsequently 
unable to produce di-rhamnolipid as judged by TLC analysis of mono- and di-rhamnolipid in 
the culture supernatants. The authors also showed that this mutant did not affect the levels 
of mono-rhamnolipid, but the rhlA null mutant was unable to produce both mono- and di-
rhamnolipid. Interestingly, levels of the di-rhamnolipid appeared to increase in the 
stationary phase of growth, suggesting a possible role for it in allelopathy.  
 
The majority of Streptococci produce rhamnose rich lipo-oligosaccharides on their cell-
surface as either non-capsular Lancefield antigens or capsule polysaccharides (32). Although 
recent work has begun to biochemically characterize enzymes responsible for the 
biosynthesis of these rhamnose-rich carbohydrates (17, 43), the identity of three important 
rhamnosyltransferases was uncovered over a decade ago for Streptococcus mutans (87). In 
this work, Shibata et al., were able to analyse LPS profiles of E. coli strains harbouring 
various combinations of genes from the S. mutans rhamnose-glucose polysaccharide (RGP) 
pathway. Using Tricine-SDS-PAGE analysis, they showed that an E. coli transformant 
harbouring rgpA was able to produce a lipooligosaccharide with an additional rhamnose 
residue and were also able to use similar experiments to show that rgpB and rgpF can 
further rhamnosylate these lipooligosaccharide samples. Based on these early findings, 
Shibata et al., were first able to propose that RgpA, RgpB, and RgpF, utilize TDP-rhamnose 
for rhamnose polysaccharide biosynthesis.  
 
Eukaryotic rhamnosyltransferases characterized in vitro 
 
Possibly the first example of successful expression, purification, and biochemical 
characterization of a rhamnosyltransferase was reported in 1991. Bar-Peled et al. 
homogenously purified a flavanone-7-O-glucoside-2”-O-rhamnosyltransferase responsible 
for the rhamnosylation of the bitter flavanone glucosides, naringin and neo-hesperidin (97). 
In this work, Bar-Peled et al. underwent a thorough column chromatography strategy to 
purify the rhamnosyltransferase >2700 fold from extracts of young pumelo leaves. The 
purified enzyme was able to selectively transfer rhamnose from UDP-ß-L-rhamnose to 
flavonoid-7-O-glucosides, but interestingly not to 5-O-glucosides or flavonoid aglycones. The 
authors then performed a detailed biochemical analysis, showing that the enzyme only 
rhamnosylates with the donor substrate UDP-ß-L-rhamnose, and detailing the relative 
activities for a number of other acceptor substrates. Further work from Bar-Peled and co-
workers, published in 2004 with improved genomic data, allowed the identification of the 
Cm1,2RhaT gene from pumelo that was responsible for this rhamnosyltransferase activity 
observed first in 1991 (19). In this work, Frydman et al. showed that the 1,2-
rhamnosyltransferase enzyme responsible for the bitter taste of species such as grapefruit 
and pumelo, is only found in neohesperidoside-producing citrus species. Using RT-PCR they 
revealed that the expression of this gene is significantly upregulated in young tissue, which 
is in agreement with the developmental pattern of flavanone-neohesperidosides 
accumulating in younger tissues.  
 
Flavanol glycosides are one of the most prominent natural product classes found in the 
model plant species, Arabidopsis thaliana. Despite this abundant present in nature, no 
flavonoid glycosyltransferases had been biochemically characterized from A. thaliana until 
2003. Jones et al. conducted an in planta and in vitro approach, to characterize both a UDP-
rhamnose:flavonol-3-O-rhamnosyltransferase and UDP-glucose:flavonol-3-O-glycoside-7-O-
glucosyltransferase (80). In this work, the authors used LC-MS to analyse the presence or 
absence of rhamnosylated/glucosylated glycosides in the mutant lines ugt78D1 and 
ugt73C6, proposing that ugt78D1 was a rhamnosyltransferase responsible for the formation 
of quercetin-3-O-rhamnoside. The authors also recombinantly expressed UGT78D1 in E. coli 
as a GST-fusion, but this enzyme lost activity rapidly. Therefore, subsequent assays were 
performed with crude extracts of E. coli harbouring the rhamnosyltransferase-containing 
plasmid. Mixtures of recombinant UGT78D1 combined with a UDP-rhamnose preparation, 
and the acceptor compound quercetin resulted in production of quercetin-3-O-rhamnoside, 
in agreement with their in planta data that UGT78D1 is flavonol-3-O-rhamnosyltransferase. 
 
Soybean (Glycine max) is another plant containing an abundance of flavonol glycosides. Like 
Jones et al., in 2014 Rodas et al. took both an in planta and in vitro approach in order to 
functionally characterize a flavonol  3-O-glucoside-1,6-rhamnosyltransferase (82). In this 
work the authors used HPLC to investigate the flavonol glycosides produced by a number of 
recombinant inbred lines, which were developed by crossing Kitakomachi and Koganejiro 
cultivars of soybean. The authors found that the flavonol glycosides of Koganejiro were 
rhamnosylated, whereas flavonol glycosides of Kitakomachi did not contain rhamnose. 
Using this methodology, the authors identified a candidate gene for this specific 
rhamnosyltransferase activity, designated GmF3G6”Rt (UGT79A6). An in vitro assay was 
developed for recombinantly produced UGT79A6 and subsequent HPLC and MS analysis of 
the reaction products confirmed that UGT79A6 was a rhamnosyltransferase, which 
produced kaempferol 3-O-rutinoside (rhamnosylated) utilising kaempferol 3-O-glucoside 
and UDP-rhamnose. The authors showed that the activity was specific for UDP-rhamnose, as 
UGT79A6 could not utilise UDP-glucose, UDP-galactose, or UDP-glucuronic acid as sugar-
donors.  
 
To date, only a single rhamnosyltransferase from eukaryotes has been crystallised; the 
flavonol α-7-O-L-rhamnosyltransferase, UGT89C1, from A. thaliana. Zong et al., recently 
reported the crystal structure of this plant rhamnosyltransferase in complex  with the sugar-
donor, UDP-rhamnose, and the flavonol acceptor, quecertin (98). Having previously been 
characterized as a flavonol-7-O-L-rhamnosyltransferase based on a combination of in planta 
and in vitro work (21), Zong and co-workers used mutagenesis studies to shed detailed 
insight into key amino acid residues for sugar donor recognition and specificity for UDP-
rhamnose. The mutant H357Q, in particular, was shown to exhibit activity with both UDP-
rhamnose and UDP-glucose. Discovery of key active site amino acids, like this histidine 
sidechain, are important for the bioinformatic-based prediction of whether a 
glycosyltransferase may be a rhamnosyltransferase or have other sugar-donor specificity. 
Interestingly, of the six rhamnosyltransferases that have been crystallised to date, all display 




Prokaryotic rhamnosyltransferases characterized in vitro 
 
The first crystal structure of a rhamnosyltransferase was reported by Steiner et al., in 2010, 
when they successfully solved the structure of the β-1,2-rhamnosyltransferase WsaF from 
Geobacillus stearothermophilus (52) (Figure 3). WsaF is responsible, along with WsaE, for 
the generation of a trirhamnan repeating unit of the polyrhamnan that decorates proteins 
in the S-layer in G. stearothermophilus. Steiner et al. revealed through recombinant 
expression in 2008, that WsaE is a trifunctional rhamnosyltransferase responsible for both 
methylation and generation of independent α-1,2 and α-1,3-linked rhamnose residues in 
the growing polyrhamnan chain (88). Using a clever design of truncated enzyme constructs 
that included or excluded these individual domains, the authors were able to use TLC 
analysis with an octyl-linked oligosaccharide acceptor to show that both glycosyltransferase 
domains were needed for the full activity of the enzyme, and that the C-terminal 
glycosyltransferase was responsible for the α-1,2-rhamnosyltransferase activity. In the same 
work, the authors also recombinantly expressed and purified WsaF. Using an octyl-linked 
oligosaccharide and TLC analysis, they showed that WsaF is a rhamnosyltransferase that 
adds a single rhamnose to the growing chain. Using NMR spectroscopy, the authors were 
able to show that the new rhamnose introduced by WsaF was of a β-1,2-linkage, and that 
the additional rhamnosyltransferase domain of WsaE was transferring rhamnose in an α-
1,3-linkage.  Alongside WsaE and WsaF, Steiner et al. used a similar approach to 
characterize two further rhamnosyltransferases, WsaC and WsaD. The authors found that 
these two α-1,3-rhamnosyltransferases were responsible for the addition of a single 
rhamnose residue each to the adaptor saccharide region (88).  
 
Just two years after the first crystal structure of WsaF was published, the crystal structure of 
another rhamnosyltransferase was revealed (99). SpnG is a rhamnosyltransferase 
responsible for the final tailoring of the spinosyns A and D. The spinosyns are complex 
polyketides produced by the actinomycete Saccharopolyspora spinose and make up the 
active ingredient of pesticides. SpnG crystallised as a homodimer, as it has been observed 
for other glycosyltransferases belonging to the GT1 family (102, 103). This crystal structure 
highlighted the importance of residues H13 and D316 in SpnG activity, in agreement to 
previous reports in 2009  (76). The crystal structure also highlighted how SpnG was selective 
for TDP-sugars over UDP-sugars; the amine of the Asn202 sidechain forms a hydrogen bond 
with the 3-OH from the thymidine moiety whilst also preventing ribose-containing 
nucleotides from binding due to clashes with 2’-OH.  
 
N-linked glycosylation is a common posttranslational modification of proteins across all 
domains of life, which contributes to the correct folding, localization, and signalling of 
cellular proteins. Typically, proteins are glycosylated with either glucose, or more commonly 
N-acetylglucosamine. Recently, a novel form of arginine glycosylation with rhamnose has 
been discovered in Pseudomonas aeruginosa, Pseudomonas putida, Shewanella oneidensis, 
and Neisseria meningitidis (90-93). Known as EarP enzymes, these rhamnosyltransferases 
have been shown to rhamnosylate translation elongation factor P. This translational 
modification   has been shown to be crucial for the rescue of polyproline-stalled ribosomes, 
and for the pathogenicity of organisms such as Pseudomonas aeruginosa (104). A structural 
basis for this arginine rhamnosylation was uncovered by Krafczyk and coworkers in 2017 
when they crystallised EarP from Pseudomonas putida (91). This work has been crucial in 
identifying important active site residues and catalytic residues such as Asp20. This 
conserved residue was also described by Sengoku et al. in their report of the crystal 
structure of the EarP homolog from Neisseria meningitidis in 2018 (100). The latest of these 
EarP rhamnosyltransferases to be crystallised was EarP from Pseudomonas aeruginosa by 
He and co-workers (101). Interestingly, EarP from Pseudomonas aeruginosa was shown to 
display important conformational changes upon TDP-rhamnose and translation elongation 
factor P binding; with sugar-donor binding enhancing acceptor binding.  The continued 
study of these novel rhamnosyltransferases and future development of drug discovery 
screens should be a key focus for the upcoming years.  
 
Only the WsaF enzyme from Geobacillus stearothermophilus has a retaining mechanism of 
action, whilst all other reported structural studies reported an inverting mechanism of 
catalysis, alternating the stereochemistry of the nucleotide sugar donor during catalysis to 
generate the product (Figure 3). Four of the reported structures are functional dimers, with 
only WsaF and SpnG, from Saccharopolyspora spinosa, being functional homodimers. A 
major structural difference between the retaining WsaF enzyme and the inverting SpnG, 
from Saccharopolyspora spinosa is that the dimerization interface appears to be on the 
opposite site (Figure 3). Further structural and functional characterisation is required to 
reveal if this is a common tertiary structure feature for retaining and inverting 
rhamnosyltransferase. 
 
In Mycobacterium tuberculosis, the conserved gene wbbL encodes an inverting 
rhamnosyltransferase responsible for the transfer of α-1,3-rhamnose from TDP-ß-L-
rhamnose to the GlcNAc moiety of decaprenyldiphosphoryl-α-D-GlcNAc. This growing lipo-
oligosaccharide chain is then further elongated with galactofuranose and arabinofuranose 
units before being transferred onto peptidoglycan. Grzegorzewicz et al. were able to 
recombinantly assay WbbL’s activity by overexpression in E. coli and purifying the WbbL-
containing membrane fractions (105). Using this methodology, the authors created a plate-
based assay using the natural substrate, GlcNAc-PP-decaprenyl, and were able to 
characterize pH optima, metal dependency, and kinetic parameters for WbbL.  
An enzyme with a similar rhamnosyltransferase activity, GacB, has been characterized from 
the human exclusive pathogen Streptococcus pyogenes (Group A Streptococcus). Zorzoli, 
Meyer et al. reported that GacB, like WbbL, is responsible for the rhamnosylation of a 
GlcNAc-PP-undecaprenyl substrate in vivo (17). In Group A Streptococcus, this primed lipo-
dissacharide is then further elongated with α-1,3- and α-1,2-rhamnose residues, before 
having GlcNAc side-chains incorporated that are further decorated with glycerol-phosphate 
modifications to build the Group A Carbohydrate virulence factor (43). Zorzoli et al. 
genetically incorporated streptococcal polyrhamnose biosynthesis gene clusters into E. coli 
using parts of the gene cluster from Streptococcus mutans and used antibodies against the 
polyrhamnose product as a marker to investigate the effects of manipulating individual 
genes. Using this strategy, GacB was shown to be essential for polyrhamnose biosynthesis 
(RhaPS). Using radiolabelling experiments, GacB was proposed to transfer a single rhamnose 
residue to the growing lipid-linked oligosaccharide, which was confirmed in vitro by 
detergent extracting the GacB enzyme from E. coli membrane fractions and assaying using 
MALDI-TOF. This in vitro assay was also used to show that GacB is metal independent, and 
NMR analysis of the reaction product confirmed that GacB is a novel retaining 
rhamnosyltransferase producing a ß-1,4 linkage, unlike WbbL, which is an α-1,3-
rhamnosyltransferase (105). Strikingly, the authors revealed that the GacB enzyme produces 
the first committed step not only in Group A Streptococcus and S. mutans, but also is 
conserved in the RhaPS biosynthesis gene cluster of Group B, Group C, and Group G 
Lancefield Streptococci. This conservation and the essentiality of the gacB gene and its 
homologs has significant implications for the future development of novel streptococcal 
drug candidates. 
Viral rhamnosyltransferases characterized in vitro 
Very recently, Speciale et al. biochemically characterized the rhamnosyltransferase activity 
of a multifunctional enzyme from the algal-infecting giant virus, PBCV-1 (58). In this work, 
the authors showed that A064R contains 3 domains; 2 of which have ß-1,4- and α-1,2-
rhamnosyltransferase activity, with the third responsible for 2-O-methyltransferase activity 
which installs the 2-OMe group on the terminal rhamnose residue (58). In this work, the 
authors used several synthetic lipo-oligosaccharides and constructs of A064R varying in 
length, together with HPLC analysis, to characterize the activity of each domain. Both 
rhamnosyltransferases domains were shown to use UDP-β-L-rhamnose as the L-rhamnose 
nucleotide sugar donor. A064R-D1 was shown to encode the ß-1,4-rhamnosyltransferase 
activity required to install the first rhamnose at the 4’-OH position of the xylose  residue. 
A064R-D2 was shown to encode an α-1,2-rhamnosyltransferase responsible for installing 
the terminal rhamnose residue onto the previously installed L-rhamnose. After both 
rhamnose residues are installed, A064R-D3 was shown to methylate the terminal rhamnose 
at the 2’-OH position. This breakthrough work is, to our knowledge, the first example of a 
biochemically characterized viral rhamnosyltransferase, and sheds light on how giant viruses 
have evolved to perform N-glycosylation. 
Concluding remarks and perspectives 
Rhamnose, in both the L- and D-form, is found widespread in plant and microbial natural 
products and surface glycans. It is particularly prevalent in lipopolysaccharides and surface 
carbohydrate in Gram-positive and Gram-negative bacteria. Strikingly, rhamnose and any 
nucleotide-rhamnose biosynthesis enzymes are entirely absent from animals and higher 
eukaryotes. This distinction has often led to the proposal to screen for small molecule 
inhibitors to target those enzymes that synthesise or utilise rhamnose-nucleotide sugars, 
which are ideal drug targets as they are often essential in pathogenic bacteria and absent in 
humans. A number of projects have focused on bacterial enzymes involved in the 
biosynthesis of TDP-β-L-rhamnose, including inhibitor screens and optimization to target 
successfully the first enzyme of the pathway, RmlA (62, 67). However, it is also noteworthy 
to highlight that there is no report of any drug discovery programme operated by academia 
or industry to develop these small molecule inhibitors into lead compounds for drug 
discovery pipelines. It is commonly known that the financial costs to develop novel 
antimicrobial drugs is hindering those developments. Researchers and private as well as 
governmental funding bodies need to continue working together to increase the 
opportunities to successfully develop a generation of new antimicrobial drugs, including 
those targeting the human and veterinary absent sugars L- and D-Rha. 
 
The absence of any rhamnose in humans has also been exploited for vaccine development 
to prevent infections from pathogenic bacteria, including Shigella and the Streptococcus 
genus. A particularly well investigated glycoconjugate vaccine candidate has been 
developed over the past two decades for Shigella dysenteriae serotype 1. This vaccine 
candidate is composed of a carrier protein that carries recombinantly produced Shigella 
dysenteriae serotype 1 surface polysaccharides, which contain a rhamnose repeat unit (Fig 
1). Clinical trials were found safe and immunogenic in a phase I clinical trial (106). Preclinical 
trials in animals have shown that the Group A Carbohydrate backbone is also a strong 
immunogenic vaccine candidate and is currently exploited by several research groups and 
industry (33). This unique opportunity will hopefully benefit the vaccine development of a 
number of pathogenic bacteria, that produce similar, rhamnose-containing glycoconjugates 
on their surface. 
 
The biological activity of many rhamnosyltransferases has been revealed and the CAZy 
database continues to be an invaluable resource for the cataloguing of glycosyltransferases. 
The current difficulties in characterizing the rhamnosyltransferase function in vitro are often 
linked to the biological and physiochemical properties of the enzymes, in particular the 
membrane association due to the lipid-linked nature of their acceptor substrates. These 
features significantly reduce the chances to crystallize a full length or functional 
rhamnosyltransferase. Another major limitation is the access to affordable quantities of 
TDP- or UDP-rhamnose. In addition, radiolabelled derivatives of TDP- or UDP-rhamnose are 
not available – in comparison to other nucleotide sugars - challenging the researchers to 
develop their bespoke analytical systems and tools. The huge diversity of the acceptor 
substrates, in particular with regards to the lipid linked carbohydrates, is a significant 
obstacle to reveal functional insights into the enzymes under study. These tools need to be 
continuously developed and made widely accessible to study rhamnosyltransferases.  
These current constraints result in fewer studies conducted on these classes of enzymes and 
the majority of studies has relied on genetic manipulation of host organisms or semi-crude 
purifications of the target enzyme. Only half a dozen of rhamnosyltransferases have been 
purified to homogeneity and crystallised. As more structures of rhamnosyltransferase 
families become available, detailed insights into their biochemistry will be revealed and can 
be exploited to develop better tools to study related rhamnosyltransferases. This progress 
and development will ultimately benefit the discovery of the first inhibitors to target 
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Figure 1 – Examples of structurally characterised rhamnose-containing glycoconjugates found across nature. The pectic polysaccharide in plant cell 
walls, RG-I; O-antigens of Shigella dysenteriae Type I and Shigella flexneri 5a (RU = repeat units); Polyrhamnan from the S-layer glycan of G. stearo-
thermophilus NRS 2004/3a and an S-layer glycan of Paenibacillus alvei CCM 2051; Lancefield antigens from Group A and B Streptococcus, Strepto-
coccus mutans serotype C; N-glycan from Chlorovirus PBCV-1. 
Figure 2 – Biosynthesis pathways of nucleotide activated L- and D-Rha. NDP--L-rhamnose is the most common form of activated rham-
nose in nature. Successive dehydration, epimerization, and reduction steps are either conducted via three enzymes (bacteria, archaea, 
phages and some microalgae - RmlB to RmlD), or by a single or two enzymes (plants, fungi, viruses, and other eukaryotic algae - NRS/ER 
pathway or RHM). GDP--D-rhamnose biosynthesis is less prevalent and has only been reported in Aneurinibacillus, chlorovirus PBCV-1, 
and Pseudomonas, where D-Rha is widespread throughout the genus (71). 
Figure 3 – Timeline of rhamnosyltransferase crystal structures deposited to the PDB database with their PDB IDs. Dark 
domains refer to the N-terminal sequence, whilst bright coloured domains highlight the C-terminal domain. (a) crystal 
structure of the -1,2-rhamnosyltransferase, WsaF, from Geobacillus stearothermophilus (52); (b) crystal structure of Spino-
syn 9-O-α-L-rhamnosyltransferase, SpnG, from Saccharopolyspora spinosa (99); (c) crystal structure of arginine α-L-rhamnos-
yltransferase, EarP, from Pseudomonas putida (91); (d) crystal structure of arginine α-L-rhamnosyltransferase, EarP, from 
Neisseria meningitidis (100); (e) crystal structure of arginine α-L-rhamnosyltransferase, EarP, from Pseudomonas aeruginosa 
(101); (f ) crystal structure of the flavonol α-7-O-L-rhamnosyltransferase, UGT89C1, from Arabidopsis thaliana (98).
 
Family Name Activity Host organism Genbank Reference 




ADU86026.1 (72)  
 




ADU85989.1 (72)  
 
GT1 RtfA GPL/6-deoxytalose α-L-1,2-
rhamnosyltransferase A 
Mycobacterium avium AAD44209.1 (18)  
 





AAN28688.1 (73)  
 




CAB05415.1 (74)  
 
GT1 RhlB rhamnosyltransferase Pseudomonas 
aeruginosa 
AAG06866.1 (75)  
 




AAG23268.1 (76)  
 
GT1 AraGT α-L-rhamnosyltransferase 
(aranciamycin synthase) 
Streptomyces echinatus ABL09968.1 (77)  
 
GT1 ElmGT 8-demethyl-tetracenomycin 
C α-L-rhamnosyltransferase 
Streptomyces olivaceus CAC16413.2 (78)  
 




CAJ42338.1 (79)  
EUKARYOTE GT1 UGT78D1 flavonol-3-O-
rhamnosyltransferase 
Arabidopsis thaliana OAP13716.1 (80)  
 
GT1 UGT89C1 flavonol α-7-O-L-
rhamnosyltransferase 
Arabidopsis thaliana AAF80123.1 (21)  
 
GT1 C12RT1 flavonoid α-1,2-L-
rhamnosyltransferase 
Citrus maxima AAU99997.1 (81)  
 
GT1 UGT79A6 flavonol 3-O-glucoside α-1,6- 
L-rhamnosyltransferase 
Glycine max BAN91401.1 (82)  
 
GT1 UGT72 anthocyanidin-3-glucoside 
α- L-rhamnosyltransferase 
Petunia x hybrida CAA50376.1 (83)  
 
GT1 Sgt3 β-solanine/β-chaconine 
rhamnosyltransferase 
Solanum tuberosum ABB84472.1 (20)  




AFN51271.1 (84)  
 











AAG04519.1 (85)  
 




AAG04094.1 (16)  
 
GT2 RfbF L-Rha α-1,2-
rhamnosyltransferase 
Shigella flexneri 02A CAA50772.1 (86)  
 GT2 RgpB α-1,3-
rhamnosyltransferase* 
Streptococcus mutans Q840W4 (87) 
 GT2 WsaC α-1,3-rhamnosyltransferase Geobacillus 
stearothermophilus 
Q7BG54 (88) 
 GT2 WsaD α-1,3-rhamnosyltransferase Geobacillus 
stearothermophilus 
Q7BG45 (88) 





PROKARYOTE GT4 RgpA α- D-GlcNAc-β-1,4-
rhamnosyltransferase* 
Streptococcus mutans Q840W5 (87) 
 GT4 WsaF β-1,2-rhamnosyltransferase Geobacillus 
stearothermophilus 
Q7BG50 (88) 
 GT4 GacB α- D-GlcNAc-β-1,4-
rhamnosyltransferase 
Streptococcus pyogenes N/A (17) 
PROKARYOTE GT102 WbbB Multimodular 
glycosyltransferase 
catalyzing glycan 
polymerization and chain 
termination 
Raoultella terrigena AAQ82931.1 (89)  




AAG06240.1 (90)  
 
GT104 EarP arginine α-L-
rhamnosyltransferase 
Pseudomonas putida AAN67476.1 (91)  
 
GT104 EarP arginine α-L-
rhamnosyltransferase 
Shewanella oneidensis AAN55363.1 (92)  
 
GT104 EarP arginine α-L-
rhamnosyltransferase 
Neisseria meningitidis BAU19337.1 (93)  
EUKARYOTE GT106 RRT1 rhamnogalacturonan-I 
rhamnosyltransferase 
Arabidopsis thaliana CAC01773.1 (94)  
 
GT106 RRT2 rhamnogalacturonan-I 
rhamnosyltransferase 
Arabidopsis thaliana AEE73784.1 (94)  
 
GT106 RRT3 rhamnogalacturonan-I 
rhamnosyltransferase 
Arabidopsis thaliana AEC05682.1 (94)  
 
GT106 RRT4 rhamnogalacturonan-I 
rhamnosyltransferase 
Arabidopsis thaliana AEE29099.1 (94)  
PROKARYOTE Unknown RgpF Multidomain α-1,3- and α-
1,2-rhamnosyltransferase* 
Streptococcus mutans Q840W3 (87) 
VIRAL Unknown A064R Multidomain β-1,4- and α-
1,2-rhamnosyltransferase 
PBCV-1 Q89399 (58) 
 
 
